Literature DB >> 25584358

Acute Retinal Necrosis with Multiple Viral Infections: A Case Report.

Shida Chen1, Khurram J Malik2, Defen Shen3, Chi-Chao Chan3.   

Abstract

A 52-year-old male presented with acute retinal necrosis in his left eye. Slit lamp examination revealed stellate keratic precipitates and cells in the anterior chamber and vitreous. Funduscopy of his left eye revealed multiple yellow deposits. Pathological examination of the vitreous showed both small, reactive lymphocytes and a few macrophages. IL-6 and IFN-γ were elevated in the vitreous. Microdissected macrophages from the vitreous revealed DNAs from multiple viruses. The patient responded to oral valacyclovir. We conclude that multiple viral infections can be involved in the pathogenesis of acute retinal necrosis and that adequate anti-viral therapy has a beneficial effect on disease progression. However, retinal detachment can be a consequence for a poor visual outcome.

Entities:  

Keywords:  Acute retinal necrosis; Anti-viral treatment; Viral infection

Year:  2014        PMID: 25584358      PMCID: PMC4288818          DOI: 10.4172/2324-8599.1000151

Source DB:  PubMed          Journal:  Int J Ophthalmic Pathol        ISSN: 2324-8599


  14 in total

Review 1.  The role of IFN-gamma in immune responses to viral infections of the central nervous system.

Authors:  David A Chesler; Carol Shoshkes Reiss
Journal:  Cytokine Growth Factor Rev       Date:  2002-12       Impact factor: 7.638

2.  Standard diagnostic criteria for the acute retinal necrosis syndrome. Executive Committee of the American Uveitis Society.

Authors:  G N Holland
Journal:  Am J Ophthalmol       Date:  1994-05-15       Impact factor: 5.258

3.  Acute retinal necrosis features, management, and outcomes.

Authors:  Chun H Lau; Tom Missotten; Joel Salzmann; Susan L Lightman
Journal:  Ophthalmology       Date:  2006-12-20       Impact factor: 12.079

4.  Comprehensive PCR-based assay for detection and species identification of human herpesviruses.

Authors:  G Johnson; S Nelson; M Petric; R Tellier
Journal:  J Clin Microbiol       Date:  2000-09       Impact factor: 5.948

5.  Treatment of acute retinal necrosis syndrome with oral antiviral medications.

Authors:  Alexander Aizman; Mark W Johnson; Susan G Elner
Journal:  Ophthalmology       Date:  2006-11-21       Impact factor: 12.079

6.  Long-term follow-up of acute retinal necrosis.

Authors:  Beeran Meghpara; Gregory Sulkowski; Muge R Kesen; Howard H Tessler; Debra A Goldstein
Journal:  Retina       Date:  2010-05       Impact factor: 4.256

7.  Acute retinal necrosis associated with Epstein-Barr virus: immunohistopathologic confirmation.

Authors:  Shlomit Schaal; Aleksandr Kagan; Yujuan Wang; Chi-Chao Chan; Henry J Kaplan
Journal:  JAMA Ophthalmol       Date:  2014-07       Impact factor: 7.389

8.  Retinal detachment following the acute retinal necrosis syndrome.

Authors:  J G Clarkson; M S Blumenkranz; W W Culbertson; H W Flynn; M L Lewis
Journal:  Ophthalmology       Date:  1984-12       Impact factor: 12.079

9.  Acute retinal necrosis: clinical features, management and outcomes--a 10 year consecutive case series.

Authors:  Rupak Roy; Bikramjit P Pal; Gaurav Mathur; Chetan Rao; Debmalya Das; Jyotirmay Biswas
Journal:  Ocul Immunol Inflamm       Date:  2014-04-16       Impact factor: 3.070

10.  Acute retinal necrosis: a national population-based study to assess the incidence, methods of diagnosis, treatment strategies and outcomes in the UK.

Authors:  M N Muthiah; M Michaelides; C S Child; S M Mitchell
Journal:  Br J Ophthalmol       Date:  2007-05-15       Impact factor: 4.638

View more
  2 in total

1.  Fulminant bilateral acute retinal necrosis after chickenpox - a case report.

Authors:  Ana Maria Dascalu; Daniela Stana; Alina Popa-Cherecheanu; Matei Popa-Cherecheanu; Dragos Serban
Journal:  Rom J Ophthalmol       Date:  2016 Jul-Sep

2.  Efficacy of Oral Valacyclovir Treatment in a Case with Acute Retinal Necrosis.

Authors:  Mert Şimşek; Pınar Çakar Özdal; Kemal Tekin
Journal:  Turk J Ophthalmol       Date:  2017-06-01
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.